In last trading session, Clearmind Medicine Inc (NASDAQ:CMND) saw 0.7 million shares changing hands with its beta currently measuring -1.76. Company’s recent per share price level of $0.13 trading at $0.01 or 7.36% at ring of the bell on the day assigns it a market valuation of $1.90M. That closing price of CMND’s stock is at a discount of -4592.31% from its 52-week high price of $6.10 and is indicating a premium of 7.69% from its 52-week low price of $0.12. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.8 million shares which gives us an average trading volume of 2.03 million if we extend that period to 3-months.
Clearmind Medicine Inc (NASDAQ:CMND) trade information
Upright in the green during last session for gaining 7.36%, in the last five days CMND remained trading in the red while hitting it’s week-highest on Tuesday, 11/14/23 when the stock touched $0.13 price level, adding 7.14% to its value on the day. Clearmind Medicine Inc’s shares saw a change of -95.89% in year-to-date performance and have moved -2.33% in past 5-day. Clearmind Medicine Inc (NASDAQ:CMND) showed a performance of -12.53% in past 30-days. Number of shares sold short was 0.32 million shares which calculate 0.07 days to cover the short interests.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -231.69% during past 5 years.
CMND Dividends
Clearmind Medicine Inc is more likely to be releasing its next quarterly report in December and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Clearmind Medicine Inc (NASDAQ:CMND)’s Major holders
Insiders are in possession of 7.43% of company’s total shares while institution are holding 3.14 percent of that, with stock having share float percentage of 3.39%. Investors also watch the number of corporate investors in a company very closely, which is 3.14% institutions for Clearmind Medicine Inc that are currently holding shares of the company. AdvisorShares Investments, LLC is the top institutional holder at CMND for having 0.12 million shares of worth $58547.0. And as of Jun 29, 2023, it was holding 4.95% of the company’s outstanding shares.
The second largest institutional holder is Geode Capital Management, LLC, which was holding about 51523.0 shares on Jun 29, 2023. The number of shares represents firm’s hold over 2.07% of outstanding shares, having a total worth of $24473.0.
On the other hand, AdvisorShares Trust-AdvisorShares Psychedelics ETF and Fidelity NASDAQ Composite Index ETF are the top two Mutual Funds which own company’s shares. As of Sep 29, 2023, the former fund manager was holding 0.12 million shares of worth $19721.0 or 4.95% of the total outstanding shares. The later fund manager was in possession of 63564.0 shares on Sep 29, 2023, making its stake of worth around $10170.0 in the company or a holder of 2.55% of company’s stock.
